EFG Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,328
| Closed | -$3.04M | – | 195 |
|
|
2024
Q3 | $3.04M | Sell |
24,328
-2,275
| -9% | -$284K | 0.51% | 69 |
|
|
2024
Q2 | $4.2M | Sell |
26,603
-2,221
| -8% | -$351K | 0.73% | 31 |
|
|
2024
Q1 | $3.73M | Buy |
28,824
+3,690
| +15% | +$477K | 0.64% | 44 |
|
|
2023
Q4 | $2.42M | Buy |
25,134
+2,422
| +11% | +$233K | 0.46% | 77 |
|
|
2023
Q3 | $2.75M | Sell |
22,712
-1,582
| -7% | -$192K | 0.65% | 54 |
|
|
2023
Q2 | $2.78M | Buy |
24,294
+2,336
| +11% | +$268K | 0.6% | 56 |
|
|
2023
Q1 | $3.03M | Sell |
21,958
-1,859
| -8% | -$256K | 0.67% | 50 |
|
|
2022
Q4 | $3.03M | Buy |
23,817
+2,423
| +11% | +$308K | 0.68% | 51 |
|
|
2022
Q3 | $2.36M | Buy |
+21,394
| New | +$2.36M | 0.55% | 62 |
|